Our Mission

We are on a mission to make finger-prick blood glucose testing obsolete for people living with diabetes.

More than 164 million people in the Asia Pacific region are living with diabetes – that’s 38 percent of people with diabetes globally.

Through innovative technology, our goal is to free people living with diabetes from painful and invasive blood monitoring devices, giving them a better quality of life.

GBS Inc. is a biosensor diagnostic technology company focused on commercializing the Saliva Glucose Biosensor the Asia Pacific Region, including Australia, Indonesia, Japan and New Zealand. GBS Inc.

GBS Inc. is a proud member of The iQ Group Global, a group of companies committed to creating the medicines of the future.  What starts here changes the world.

News

Sign Up

Register for email alerts for the latest developments on the Saliva Glucose Biosensor and GBS Inc.

  • This field is for validation purposes and should be left unchanged.

The Saliva Glucose Biosensor

Replacing finger-pricks for people living with diabetes

The Saliva Glucose Biosensor is the first pain-free, non-invasive replacement for finger-prick blood glucose testing.

Through the regulatory process, we intend to demonstrate that the Saliva Glucose Biosensor can be used as a point of care test indicated for the management of diabetes, as non-adjunctive to blood glucose testing for diabetes treatment decisions.

1
Place the Saliva Glucose Biosensor in contact with saliva.
2
With the biosensor nearby, the digital app will display glucose levels, flagging the results that need attention.
3
The app provides real-time comparisons with historical data, and sends data to electronic medical record or caregiver.

For illustrative purposes only and has yet to receive regulatory approval in any jurisdiction.

Behind the Technology

Meet the team at the
Centre for Organic Electronics behind the biosensor technology.

Diabetes – A Global Epidemic

629 million people with diabetes worldwide by 2045
1 in 10 adults will have diabetes in 2045
Asia Pacific has more than one third of the world’s diabetes population

IDF Diabetes Atlas 2017